Press release
Global Fixed-Dose Combination Inhalers Market Expansion at 10.1% CAGR, Valued at $20.76 Billion by 2029
Fixed Dose Combination Inhalers Market Size
What Are the Fixed-Dose Combination Inhalers Market Size Forecast for 2025?
In recent times, the market size for fixed-dose combination inhalers has seen substantial growth. The estimated value is set to rise from $12.80 billion in 2024 to $14.12 billion in 2025, representing a compound annual growth rate (CAGR) of 10.3%. This growth rate in the past can be accredited to factors like increased expenses on healthcare, a rise in patients' preference for handy and user-friendly inhalers and an increase in the number of regulatory approvals for new combination inhalers. Additionally, the expanding usage of digital health platforms and growing emphasis on customized respiratory care have also contributed significantly to this upward trend.
What Is the Market Size Outlook for Fixed-Dose Combination Inhalers Until 2029?
In the coming years, the fixed-dose combination inhalers industry is predicted to witness swift expansion, with its value set to reach $20.76 billion by 2029, attaining a compound annual growth rate (CAGR) of 10.1%. Factors contributing to this growth during the forecast period encompass the escalating prevalence of ailments such as asthma and chronic obstructive pulmonary disease, the heightened demand for streamlined treatment schedules in respiratory care, greater recognition of the perks of inhalation therapy, a burgeoning elderly demographic, and a rise in the uptake of combination therapy. The forecast period is also expected to uncover key trends such as enhancements in inhaler device machinery, the fusion of intelligent inhaler technology, advancements in dry powder inhaler (DPI) formulations, the integration of sensors and connectivity traits, and leaps in propellant-free inhaler systems.
Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/fixed-dose-combination-inhalers-global-market-report
What Are the Major Factors Driving Demand in the Fixed-Dose Combination Inhalers Market?
The rise in asthma cases is anticipated to spur the expansion of the fixed-dose combination inhalers market in the future. Asthma is a lasting inflammatory condition of the airways which triggers breathing challenges due to the narrowing of airways and intensified mucus production. The escalating occurrence of asthma is linked to increasing air pollution, which irritates and inflames the airways, making individuals more vulnerable to respiratory troubles. Fixed-dose combination (FDC) inhalers play a role in managing asthma as they deliver two medications - a corticosteroid to lower airway inflammation and a bronchodilator to ease airway muscles, all within a single device, which boosts symptom control and compliance. For example, in November 2023, the National Asthma Council, a non-profit organization based in Australia, reported that there were 467 asthma-related fatalities in Australia in 2022, encompassing 299 females and 168 males. These figures reflect a rise from the 355 deaths recorded in 2021. Consequently, the escalating occurrence of asthma is fuelling the expansion of the fixed-dose combination inhalers market.
Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25766&type=smp
How Are End-Use Segments Shaping the Fixed-Dose Combination Inhalers Market Outlook?
The fixed-dose combination inhalers market covered in this report is segmented -
1) By Combination: Corticosteroid And Bronchodilator Combination Inhalers, Long-Acting Beta Agonist And Inhaled Corticosteroid Combination Inhalers, Triple Combination, Other Combinations
2) By Indication: Asthma, Chronic Obstructive Pulmonary Disorder, Other Indications
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies
Subsegments:
1) By Corticosteroid And Bronchodilator Combination Inhalers: Beclomethasone + Salbutamol, Fluticasone + Salmeterol, Budesonide + Formoterol
2) By Long-Acting Beta Agonist And Inhaled Corticosteroid Combination Inhalers: Salmeterol + Fluticasone, Vilanterol + Fluticasone, Formoterol + Budesonide
3) By Triple Combination: Fluticasone + Umeclidinium + Vilanterol, Beclometasone + Formoterol + Glycopyrronium, Budesonide + Glycopyrrolate + Formoterol
4) By Other Combinations: Tiotr + Olodaterol, Mometasone + Formoterol, Indacaterol + Glycopyrronium
What Are the Strategic Trends Transforming the Fixed-Dose Combination Inhalers Market Landscape?
Key businesses in the fixed-dose combination inhaler market are honing their focus on the creation of original solutions, such as fixed-dose triple combination dry powder inhalers. Their aim is to improve the effectiveness of treatment options, increase adherence in patients and streamline the control of chronic respiratory conditions like asthma and COPD. The fixed-dose triple combination dry powder inhaler is a solitary inhalation device that delivers a pre-determined dose of three medications used in the management of asthma and COPD. In November 2023, Lupin Limited, an Indian pharmaceutical firm, introduced Vilfuro G, geared towards the treatment of chronic obstructive pulmonary disease. This fixed-dose triple combination inhaler advances lung function, mitigates symptoms like cough and difficulty in breathing, and aids in the prevention of disease flare-ups. It offers a potent long-term treatment strategy for moderate to severe chronic obstructive pulmonary disease due to its daily dosage and triple-action composition.
Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25766&type=smp
Who Are the Prominent Companies in the Fixed-Dose Combination Inhalers Market by ?
Major companies operating in the fixed-dose combination inhalers market are Novartis AG., AstraZeneca plc., GlaxoSmithKline plc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim, Chiesi Farmaceutici S.p.A., Dr. Reddy's Laboratories, Cipla Ltd., Hikma Pharmaceuticals plc., Amneal Pharmaceuticals Inc., Lupin Limited, Zydus Lifesciences Ltd., Glenmark Pharmaceuticals Ltd., Orion Corporation, Alembic Pharmaceuticals Ltd., Sava Healthcare Limited, Micro Labs Limited, Indoco Remedies Ltd., Vectura Group plc., Pulmatrix Inc.
Which Region Is Expected to See the Highest CAGR in the Fixed-Dose Combination Inhalers Market?
North America was the largest region in the fixed-dose combination inhalers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fixed-dose combination inhalers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Fixed-Dose Combination Inhalers Market Expansion at 10.1% CAGR, Valued at $20.76 Billion by 2029 here
News-ID: 4157467 • Views: …
More Releases from The Business Research Company
Low Endotoxin Gelatin Market is Anticipated to Expand upto $2.38 Billion in 2029
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What Is the Forecasted Market Growth Rate of the Low Endotoxin Gelatin Industry?
The market size for low-endotoxin gelatin has experienced a significant increase in recent years. Its growth will continue, heightening from $1.72 billion in 2024 to $1.84 billion in 2025 with a steady compound annual growth rate (CAGR) of…
Ammonium Sulfate Market on Path to Hit $5.99 Billion by 2029 at 9.6% CAGR
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Ammonium Sulfate Market Outlook: What Size And CAGR Are Anticipated By 2025?
The market size for ammonium sulfate has seen substantial growth in the past few years. The market is set to increase from a value of $3.88 billion in 2024 to $4.16 billion in 2025, with a compound annual…
Global Biodegradable Hemostat Market Expansion at 10.9% CAGR, Valued at $1.48 Bi …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
What Are the Biodegradable Hemostat Market Size Forecast for 2025?
The market size for biodegradable hemostats has experienced striking growth in the past few years. From being valued at $0.88 billion in 2024, it is predicted to grow to $0.97 billion in 2025, attaining a compound annual growth rate (CAGR)…
Aerospace Interior Adhesive Market to Record 7.8% CAGR Growth Through 2029 | Glo …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Aerospace Interior Adhesive Market Outlook: How is the Market Expected to Grow by 2025?
Recent years have seen robust growth in the aerospace interior adhesive market. The market is projected to expand from $1.27 billion in 2024 to $1.34 billion in 2025, posting a compound annual growth rate (CAGR) of…
More Releases for Combination
Advancements in Cancer Combination Therapy
Cancer combination therapy, which involves the use of multiple therapeutic agents, has revolutionized cancer treatment in recent years. This approach leverages the strengths of different therapies to enhance efficacy, reduce toxicity, and overcome drug resistance, leading to better patient outcomes.The concept of combination therapy is not new. It has been used successfully in treating infectious diseases and some chronic conditions. However, its application in cancer therapy has seen significant advancements…
Combination Vaccines Market Green and Efficient: The Future of Immunization with …
Combination Vaccines Market to reach over USD 10.11 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Combination Vaccines Market Size, Share & Trends Analysis Report By Technology (Conjugate, Live, Inactivated), Age Group (Pediatric, Adult), Application (Diphtheria, Tetanus, & Pertussis (DTP), Polio, Hepatitis B, Influenza), End-use (Hospitals, Clinics), Region, Market Outlook And Industry Analysis…
Combination of light and shade
Designer awning for glass canopies mesmerises with fantastic accentuated lighting
Underglass awnings are perfect for patio roofs and conservatories. Because under a glass canopy, they have plenty of protection. One new model is the "markilux 679". It has clean lines in its design, provides plenty of shade and creates a beautiful interplay of light on the patio with its LED lights.
Unlike above-glass awnings, underglass awnings are fixed under a glass canopy.…
Combination of light and shade
Underglass awning by markilux combines clean design with effective LED technology
The "markilux 679" is a new form of solar protection for patio roofs and conservatories. The awning has a modern cubic shape, offers plenty of shade and, with LED Lines controlled by an app, ensures an attractive interplay of light on both the cover and façade of the house.
Underglass awnings are perfect for both patio roofs and conservatories. The cover,…
Combination Hypertension Agents Market - Maximum Impact on Blood Pressure: Combi …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Combination Hypertension Agents Market.
Combination Hypertension Agents Market: https://www.growthplusreports.com/report/combination-hypertension-agents-market/9169
The Combination Hypertension Agents Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the…
Fixed-Dose Combination Drugs Market - Leading Innovation in Combination Drug Del …
Newark, New Castle, USA - new report, titled Fixed-Dose Combination Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Fixed-Dose Combination Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Fixed-Dose Combination Drugs market. The report offers an overview of…
